Nicotinic receptors as CNS targets for Parkinson's disease

This publication has 126 references indexed in Scilit:

• Partial Recovery of Striatal Nicotinic Receptors in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-Lesioned Monkeys with Chronic Oral Nicotine
  The Journal of Pharmacology and Experimental Therapeutics, 2006
• Nicotine partially protects against paraquat‐induced nigrostriatal damage in mice; link to α6β2* nAChRs
  Journal of Neurochemistry, 2006
• Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2006
• Diagnosis and treatment of Parkinson disease: molecules to medicine
  Journal of Clinical Investigation, 2006
• Aging of the nigrostriatal system in the squirrel monkey
  Journal of Comparative Neurology, 2004
• L-DOPA Treatment Modulates Nicotinic Receptors in Monkey Striatum
  Molecular Pharmacology, 2003
• Localization of [³H]nicotine, [³H]cytisine, [³H]epibatidine, and [¹²⁵I]α‐bungarotoxin binding sites in the brain of Macaca mulatta
  Journal of Comparative Neurology, 2003
• (S)-(−)-5-Ethynyl-3-(1-methyl-2-pyrroli- dinyl)pyridine Maleate (SIB-1508Y): A Novel Anti-Parkinsonian Agent with Selectivity for Neuronal Nicotinic Acetylcholine Receptors
  Journal of Medicinal Chemistry, 1996
• Beneficial effects of nicotine and cigarette smoking: the real, the possible and the spurious
  British Medical Bulletin, 1996
• Distinct nigrostriatal projection systems innervate striosomes and matrix in the primate striatum
  Brain Research, 1989